Caissa Capital Management ltd. - 10 Apr 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
10 Apr 2023
Net transactions value
+$142,516
Form type
4
Filing time
11 Apr 2023, 16:51:36 UTC
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $71,436 +31,329 +2.6% $2.28 1,242,700 10 Apr 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $71,080 +25,000 +2% $2.84* 1,267,700 11 Apr 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182,300 10 Apr 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.835 to $2.51, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.41 to $3.225, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.